Answers are grounded in this paper and cite their sources.
Advances in genome sequencing technology have fostered a new era of clinical genomic medicine. Genetic counselors, who have begun to support patients undergoing multi-gene panel testing for hereditary cancer risk, will review brief clinical vignettes, and discuss early experiences with clinical genomic testing. Their experiences will frame a discussion about how current testing may challenge patient understanding and expectations toward the evaluation of cancer risk and downstream preventive behaviors.
No takes yet. Share an insight, caveat, or question.
Hall et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: